IL1A and neoplasm: By promoting inflammation and specifically IL-1 release, ASC may indirectly exert pro-tumor activities by inducing chronic inflammation, angiogenesis, activation of the IL-17 pathway, myeloid-derived suppressor cell differentiation, and macrophage recruitment, invasion, and metastasis (Mantovani et al., 2018).